Clinical trial
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With…
NCT00100802 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00100802 |
|---|---|
| Title | Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas |
| Official title | A Phase II Study of Concurrent Radiation and Temozolomide Followed By Temozolomide and CCNU in the Treatment of Children With High-Grade Glioma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anaplastic Astrocytoma, Central Nervous System Neoplasm, Glioblastoma, Gliosarcoma, Spinal Cord Neoplasm |
| Intervention type | Drug, Other, Radiation |
| Interventions | Laboratory Biomarker Analysis, Lomustine, Radiation Therapy, Temozolomide |
| Enrollment | 118 |
| Start date | Mar 21, 2005 |
| Primary completion | Sep 1, 2012 |
| Completion | Jun 30, 2017 |
| First posted | Jan 7, 2005 |
| Last update posted | Feb 15, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: